TY  - GEN
AU  - Bajetta,E
AU  - Di Bartolomeo,M
AU  - Buzzoni,R
AU  - Mariani,L
AU  - Zilembo,N
AU  - Ferrario,E
AU  - Lo Vullo,S
AU  - Aitini,E
AU  - Isa,L
AU  - Barone,C
AU  - Jacobelli,S
AU  - Recaldin,E
AU  - Pinotti,G
AU  - Iop,A
TI  - Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
SN  - 0007-0920
PY  - 2007///0321
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Camptothecin
KW  - administration & dosage
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Irinotecan
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Tegafur
KW  - Uracil
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1038/sj.bjc.6603493
ER  -